第 53 卷第 3 期 |  | Vol. 53 No. 3 | 2023 年 6 月 | Jun 2023 |
|
所屬欄目:分析與測試
HPLC檢測器聯(lián)用法測定瑞格列奈二甲雙胍片中瑞格列奈的有關(guān)物質(zhì) |
張 琳1,2,3,劉 林1,顏 紅1,邢雪敏1*,劉葵葵1,李 欣1
(1. 山東省藥學(xué)科學(xué)院 山東省化學(xué)藥物重點(diǎn)實(shí)驗室,山東 濟南 250101;2. 山東福瑞達醫藥集團有限公司,山東 濟南 250101;3. 山東省黏膜與皮膚給藥技術(shù)重點(diǎn)實(shí)驗室,山東 濟南 250101) |
摘 要:建立二極管陣列及熒光檢測器聯(lián)用的HPLC方法測定瑞格列奈二甲雙胍片中瑞格列奈的有關(guān)物質(zhì)。以辛烷基硅烷鍵合硅膠為填充劑,以磷酸二氫鉀緩沖溶液與乙腈為流動(dòng)相,采用梯度洗脫分離;檢測器為二極管陣列與熒光檢測器串聯(lián),二極管陣列檢測器檢測波長(cháng)240 nm,熒光檢測器激發(fā)波長(cháng)244 nm、發(fā)射波長(cháng)348 nm;流速1.0 mL/min,進(jìn)樣體積50 μL,柱溫40 ℃。兩種檢測器條件下主峰及各雜質(zhì)之間分離度均較好;各雜質(zhì)及瑞格列奈檢測限分別為0.012、0.020、0.103、0.088、0.073、0.024 ng/mL,定量限依次為0.053、0.060、0.309、0.264、0.219、0.072 ng/mL;主峰及各雜質(zhì)在1~50 ng/mL濃度范圍內濃度與峰面積線(xiàn)性關(guān)系良好;五種雜質(zhì)的平均回收率為98.3%、94.2%、98.2%、96.5%、103.6%,RSD依次為3.8%、2.6%、4.1%、3.9%、5.6%(n=6);6份樣品中,雜質(zhì)1平均含量為0.05%,RSD為6.8%,其他已知雜質(zhì)均未檢出,未知雜質(zhì)未檢出;供試品溶液在8 h內穩定性良好。該方法靈敏度高,準確度和重復性均較好,可用于檢測瑞格列奈二甲雙胍片中瑞格列奈的有關(guān)物質(zhì)。 |
關(guān)鍵詞:瑞格列奈二甲雙胍片;瑞格列奈;有關(guān)物質(zhì);檢測器聯(lián)用法 |
中圖分類(lèi)號:O657.7 文獻標識碼:A 文章編號:1009-9212(2023)03-0068-05 |
|
Determine Repaglinide-related Substances in Repaglinide and Metformin Tablets Using HPLC with Combined Detectors |
ZHANG Lin1,2,3, LIU Lin1, YAN Hong1, XING Xue-min1*, LIU Kui-kui1, LI Xin1
(1. Key Laboratory for Chemical Drugs Research of Shandong Province, Shandong Academy of Pharmaceutical Sciences, Ji’nan 250101, China; 2. Shandong Freda Pharmaceutical Group Co., Ltd., Ji’nan 250101, China; 3. Shandong Provincial Key Laboratory of Mucosa and Transdermal Drug Delivery Technology, Ji’nan 250101, China) |
Abstract:The related substances of repaglinide in the repaglinide and metformin compound tablets were more accurately determined by HPLC method with diode array and fluorescence detector. Octylsilane-bonded silica gel was used as filler; potassium dihydrogen phosphate buffer solution and acetonitrile were taken as mobile phases, gradient elution was used for separation; the detector was a diode array connected in series with a fluorescence detector, which was used to detect the wavelength 240 nm. Besides, the excitation wavelength of the fluorescence detector is 244 nm; the emission wavelength is 348 nm; the flow rate was 1.0 mL/min;the injection volume was 50 μL; the column temperature was 40 ℃. The repaglinide and other impurities were well separated under the conditions of the two detectors. The limits of detection were 0.012, 0.020, 0.103, 0.088, 0.073, and 0.024 ng/mL, repectively and the limits of quantitation were 0.053, 0.060, 0.309, 0.264, 0.219, and 0.072 ng/mL, respectively. The main peak and each impurity had a good linear relationship between the concentration and the peak area in the concentration range of 1~50 ng/mL.The average recoveries of the 5 impurities were 98.3%, 94.2%, 98.2%, 96.5%, 103.6%. At the same time, the RSD were 3.8%, 2.6%, 4.1%, 3.9%, and 5.6% (n=6). The average content of impurity 1 in six smples was 0.05%, and the RSD was 6.8%. The stability of the test solution was good in the 8 h. This method has high sensitivity, good accuracy and repeatability. Therefore, it can be used to detect the related substances of repaglinide in repaglinide and metformin tablets. |
Key words:repaglinide and metformin tablets; repaglinide; related substances; combination detector |
|
作者簡(jiǎn)介:張 琳(1981—),女,山東濟南人,高級工程師,碩士,研究方向:藥物質(zhì)量控制(E-mail:25144123@qq.com)。
|
聯(lián) 系 人:邢雪敏,工程師,研究方向:藥物質(zhì)量控制(E-mail:34692577@qq.com)。
|
收稿日期:2023-03-27
|
|